Raha Osailan

Dr. Raha Osailan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
RKRashad Kebeish
Rashad Kebeish
EHEmad Hamdy
Emad Hamdy
omar mahmoud al zoubiomar mahmoud al zoubi
omar mahmoud al zoubi
Talaat Hassan HabeebTalaat Hassan Habeeb
Talaat Hassan Habeeb
RORaha Osailan
Raha Osailan
YEYassin El-Ayouty
Yassin El-Ayouty
Human interferon (IFN) is a type of cytokine that regulates the immune system’s response to viral and bacterial infections. Recombinant IFN-α has been approved for use in the treatment of a variety of viral infections as well as an anticancer medication for various forms of leukemia. The objective of the current study is to produce a functionally active recombinant human IFN-α2a from transgenic Raphanus sativus L. plants. Therefore, a binary plant expression construct containing the IFN-α2a gene coding sequence, under the regulation of the cauliflower mosaic virus 35SS promoter, was established. Agrobacterium-mediated floral dip transformation was used to introduce the IFN-α2a expression cassette into the nuclear genome of red and white rooted Raphanus sativus L. plants. From each genotype, three independent transgenic lines were established. The anticancer and antiviral activities of the partially purified recombinant IFN-α2a proteins were examined. The isolated IFN-α2a has been demonstrated to inhibit the spread of the Vesicular Stomatitis Virus (VSV). In addition, cytotoxicity and cell apoptosis assays against Hep-G2 cells (Human Hepatocellular Carcinoma) show the efficacy of the generated IFN-α2a as an anticancer agent. In comparison to bacterial, yeast, and animal cell culture systems, the overall observed results demonstrated the efficacy of using Raphanus sativus L. plants as a safe, cost-effective, and easy-to-use expression system for generating active human IFN-α2a.

20 November 2025 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
RORaha Osailan
Raha Osailan
Talaat Hassan HabeebTalaat Hassan Habeeb
Talaat Hassan Habeeb
MMMagdi Hassan Mohammed
Magdi Hassan Mohammed
ABAli Bashal
Ali Bashal